Your browser doesn't support javascript.
loading
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden.
Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla; Jerkeman, Mats; Wahlin, Bjorn E; Andersson, Per-Ola; Smedby, Karin E.
Afiliación
  • Harrysson S; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. sara.harrysson@ki.se.
  • Eloranta S; Department of Hematology, Karolinska University Hospital, Solna, Sweden. sara.harrysson@ki.se.
  • Ekberg S; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Enblad G; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Jerkeman M; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
  • Wahlin BE; Department of Oncology, Lund University, Lund, Sweden.
  • Andersson PO; Department of Hematology, Karolinska University Hospital, Solna, Sweden.
  • Smedby KE; Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Blood Cancer J ; 11(1): 9, 2021 01 07.
Article en En | MEDLINE | ID: mdl-33414443

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Neoplasias del Sistema Nervioso Central / Recurrencia Local de Neoplasia Tipo de estudio: Incidence_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Blood Cancer J Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Neoplasias del Sistema Nervioso Central / Recurrencia Local de Neoplasia Tipo de estudio: Incidence_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Blood Cancer J Año: 2021 Tipo del documento: Article